Results 141 to 150 of about 113,904,810 (178)

Targeting sirtuin 1/nuclear factor erythroid 2-related factor 2/tumor necrosis factor-α pathway to modulate hepatic ischemia reperfusion-induced injury. [PDF]

World J Hepatol
Kelleni MT, Abdelzaher WY, Adly M, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Updates in the Treatment of Pain and Pruritus in Epidermolysis Bullosa. [PDF]

Pediatr Dermatol
Lavery MJ, Rosen C, Warner J, Li H, Peterson MB.   +4 more
europepmc   +1 more source

Real-World Outcomes of Fosaprepitant-Containing Prophylaxis in Patients Receiving Highly and Moderately Emetogenic Chemotherapy: A Two-Center Retrospective Study. [PDF]

Sisli Etfal Hastan Tip Bul
Celayir OM, Korkmaz T, Sonmez O, Ataacar Aydınoglu A, Er O.   +4 more
europepmc   +1 more source

A multicenter parallel-group double-blind randomized placebo-controlled phase III clinical trial of generic aprepitant QLG2174 for the prevention of postoperative nausea and vomiting. [PDF]

Int J Surg
Li P, Li S, Du W, Huang Y, Zhang B, Wang K, Xu Z, Qin Y, Wang H, Xu X, Liu S, Zhang M, Zou T, Gao W, Luo F, Chen Z, Huang F, Ma C, Wang C, Jin S, Chen C, Jing J, Zhao L, Li J, Luo H, Yang C, Wang C, Zhang Y, Hu X, Li Y, Ning X, Yan Y, Ju Y, Wang J, Yang M, Wang Y, Luo A.   +36 more
europepmc   +1 more source

Neural regulation of lung cancer: from mechanisms to clinical implications. [PDF]

Eur J Med Res
Xu L, Sun X, Yao Y, Fang H.
europepmc   +1 more source

Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]

Medicine (Baltimore)
Chen F, Cai D, Wen H, Zhang L.
europepmc   +1 more source

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers. [PDF]

Blood Cell Ther
Yakushijin K, Perram J, Ho A, Farzana T, Iida H, Lee JW, Inamoto Y, George B, Wu D, Suzuki R, Behfar M, Huang H, Asawapanumas T, Rowlings P, Poudyal BS, Santosa D, Gyi AA, Altangerel O, Wanitpongpun C, Gan GG, Iyama S, Iqbal S, Ramzi M, Khadwal A, Kato J, Sim J, Cheng J, Ma D, Chua YX, Okamoto S, Iida M, Fuji S.   +31 more
europepmc   +1 more source

Awareness of chemotherapy-induced nausea and vomiting and adherence to guidelines: results of a multinational and multicenter survey, part of the THRIVE program. [PDF]

Support Care Cancer
Caponero R, Enrico D, Giudice F, Ayoub JP, Lapointe N.   +4 more
europepmc   +1 more source

The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet Against Cancer? [PDF]

Cancers, 2020
Neurokinin-1 receptor (NK-1R) antagonists exert antitumor action, are safe and do not cause serious side-effects. These antagonists (via the NK-1R) exert multiple actions against cancer: antiproliferative and anti-Warburg effects and apoptotic, anti-angiogenic and antimetastatic effects.
Rafael Coveñas, Miguel Muñoz
exaly   +5 more sources